CAS Venture Capital
Beijing, Beijingcasvc.com
Overview
CAS Venture Capital is a venture capital and private equity firm founded by the Chinese Academy of Sciences Holdings Co., Ltd. that focuses on technology innovation, semiconductors, and high technology. The firm operates using a Fund of Funds (FOF) and direct investment model.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Polyseq Biotech | Mar 2026 | Series B | Co-investor |
| Hunan Yanhe Technology Co., Ltd. | Oct 2025 | Series A | Co-investor |
| 中科加禾 | Jan 2025 | Series A | Co-investor |
| Shanghai UniXell Biotechnology | Jul 2024 | Series A | Co-investor |
| 中科加禾 | Mar 2024 | Angel | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
